|
FR2802206B1
(fr)
|
1999-12-14 |
2005-04-22 |
Sod Conseils Rech Applic |
Derives de 4-aminopiperidine et leur utilisation en tant que medicament
|
|
EP1451156A4
(en)
|
2001-11-27 |
2005-05-25 |
Merck & Co Inc |
4-AMINOCHINOLINVERBINDUNGEN
|
|
JP4216196B2
(ja)
|
2002-02-04 |
2009-01-28 |
エフ．ホフマン−ラ ロシュ アーゲー |
Ｎｐｙアンタゴニストとしてのキノリン誘導体
|
|
WO2005024416A1
(en)
|
2003-09-05 |
2005-03-17 |
Binghe Wang |
Water soluble boronic acid fluorescent reporter compounds and methods of use thereof
|
|
JP2008506695A
(ja)
|
2004-07-13 |
2008-03-06 |
グラクソ グループ リミテッド |
抗細菌剤
|
|
US20060183763A1
(en)
|
2004-12-31 |
2006-08-17 |
Pfizer Inc |
Novel pyrrolidyl derivatives of heteroaromatic compounds
|
|
EP1959948B1
(en)
|
2005-12-05 |
2012-07-18 |
XenoPort, Inc. |
Levodopa prodrug mesylate, compositions thereof, and uses thereof
|
|
JP2009527562A
(ja)
|
2006-02-21 |
2009-07-30 |
アムゲン インコーポレイティッド |
ホスホジエステラーゼ１０阻害剤としてのシンノリン誘導体
|
|
WO2007103554A1
(en)
|
2006-03-08 |
2007-09-13 |
Amgen Inc. |
Quinoline and isoquinoline derivatives as phosphodiesterase 10 inhibitors
|
|
US20090258853A1
(en)
|
2006-03-13 |
2009-10-15 |
Brian Eastman |
Somatostatin Agonists
|
|
US8871728B2
(en)
|
2007-06-29 |
2014-10-28 |
Georgia Tech Research Corporation |
Non-peptide macrocyclic histone deacetylese (HDAC) inhibitors and methods of making and using thereof
|
|
US20100074949A1
(en)
|
2008-08-13 |
2010-03-25 |
William Rowe |
Pharmaceutical composition and administration thereof
|
|
US20100256184A1
(en)
|
2008-08-13 |
2010-10-07 |
Vertex Pharmaceuticals Incorporated |
Pharmaceutical composition and administrations thereof
|
|
KR20110042356A
(ko)
|
2008-08-13 |
2011-04-26 |
버텍스 파마슈티칼스 인코포레이티드 |
제약 조성물 및 그의 투여
|
|
JP5564045B2
(ja)
|
2008-09-02 |
2014-07-30 |
ノバルティス アーゲー |
二環式キナーゼ阻害剤
|
|
GB0818241D0
(en)
|
2008-10-06 |
2008-11-12 |
Cancer Res Technology |
Compounds and their use
|
|
WO2012016082A1
(en)
|
2010-07-30 |
2012-02-02 |
Oncotherapy Science, Inc. |
Quinoline derivatives and melk inhibitors containing the same
|
|
NZ607494A
(en)
|
2010-08-27 |
2015-04-24 |
Vertex Pharma |
Pharmaceutical composition and administrations thereof
|
|
WO2012151567A1
(en)
|
2011-05-05 |
2012-11-08 |
St. Jude Children's Research Hospital |
Pyrimidinone compounds and methods for preventing and treating influenza
|
|
AU2012258977A1
(en)
|
2011-05-23 |
2014-01-16 |
Imago Pharmaceuticals, Inc. |
Inhibitors of LRRK2 kinase activity
|
|
US9281726B2
(en)
|
2011-05-31 |
2016-03-08 |
Linak A/S |
Actuator
|
|
US8871756B2
(en)
|
2011-08-11 |
2014-10-28 |
Hoffmann-La Roche Inc. |
Compounds for the treatment and prophylaxis of Respiratory Syncytial Virus disease
|
|
DE102011113749A1
(de)
*
|
2011-09-14 |
2013-03-14 |
Aicuris Gmbh & Co. Kg |
Sulfonsäuresalze Heterocyclylamid-substituiertr Imidazole
|
|
US20140228417A1
(en)
|
2011-10-05 |
2014-08-14 |
Mapi Pharma Ltd. |
Process and intermediates for the preparation of substituted 2-arylthiazole carboxylic acids
|
|
JP6299591B2
(ja)
|
2012-07-03 |
2018-03-28 |
小野薬品工業株式会社 |
ソマトスタチン受容体作動活性を有する化合物およびその医薬用途
|
|
KR20150039832A
(ko)
|
2012-08-06 |
2015-04-13 |
사피라 파르마슈티칼즈 게엠베하 |
디하이드록시피리미딘 탄산 유도체 및 바이러스성 질환의 치료, 개선 또는 예방에서의 이의 용도
|
|
US9713594B2
(en)
|
2012-09-11 |
2017-07-25 |
Bend Research, Inc. |
Methods for making pharmaceutical solid dosage forms of spray-dried dispersions
|
|
US9309222B2
(en)
|
2012-10-16 |
2016-04-12 |
Janssen Pharmaceutica Nv |
Phenyl linked quinolinyl modulators of RORγt
|
|
US10647664B2
(en)
|
2013-08-16 |
2020-05-12 |
Duke University |
Substituted hydroxamic acid compounds
|
|
BR112016007078A2
(pt)
|
2013-09-30 |
2017-12-12 |
Ono Pharmaceutical Co |
composto tendo atividade agonística do receptor de somatostatina e uso farmacêutico do mesmo
|
|
JO3805B1
(ar)
|
2013-10-10 |
2021-01-31 |
Araxes Pharma Llc |
مثبطات كراس جي12سي
|
|
US20170096422A1
(en)
|
2014-03-24 |
2017-04-06 |
Takeda Pharmaceutical Company Limited |
Heterocyclic compound
|
|
WO2016049568A1
(en)
|
2014-09-25 |
2016-03-31 |
Araxes Pharma Llc |
Methods and compositions for inhibition of ras
|
|
EP3317278B1
(en)
|
2015-07-01 |
2021-04-14 |
Crinetics Pharmaceuticals, Inc. |
Somatostatin modulators and uses thereof
|
|
HK1255034A1
(zh)
|
2015-07-01 |
2019-08-02 |
Crinetics Pharmaceuticals, Inc. |
生长抑素调节剂及其用途
|
|
IL284874B2
(en)
|
2015-10-30 |
2023-10-01 |
Neurocrine Biosciences Inc |
Valbenazine salts and polymorphs thereof
|
|
WO2017083431A2
(en)
|
2015-11-09 |
2017-05-18 |
Forge Therapeutics, Inc. |
Hydroxypyridinone and hydroxypyrimidinone based compounds for treating bacterial infections
|
|
MX2021006804A
(es)
|
2015-12-17 |
2023-01-13 |
Merck Patent Gmbh |
Antagonistas policiclicos del receptor 7/8 tipo toll (tlr7/8) y uso de los mismos en el tratamiento de trastornos inmunitarios.
|
|
US10597393B2
(en)
|
2016-07-07 |
2020-03-24 |
Plantex Ltd. |
Solid state forms of Palbociclib dimesylate
|
|
AU2017296392B2
(en)
|
2016-07-14 |
2020-09-24 |
Crinetics Pharmaceuticals, Inc. |
Somatostatin modulators and uses thereof
|
|
KR20190121404A
(ko)
|
2017-03-16 |
2019-10-25 |
크리네틱스 파마슈티칼스, 인크. |
소마토스타틴 조절제 및 이의 용도
|
|
WO2018208987A2
(en)
|
2017-05-10 |
2018-11-15 |
Forge Therapeutics, Inc. |
Antibacterial compounds
|
|
SG11202001129VA
(en)
|
2017-08-11 |
2020-03-30 |
Merck Patent Gmbh |
Pharmaceutical preparation comprising 3-fluoro-4-[7-methoxy-3-methyl-8-(1-methyl-1 h-pyrazol-4-yl)-2-oxo-2,3-dihydro-imidazo[4,5-c]quinolin-1 -yl]-benzonitrile
|
|
MA51625B1
(fr)
|
2018-01-17 |
2022-07-29 |
Crinetics Pharmaceuticals Inc |
Procédé de production de modulateurs de somatostatine
|
|
US10696689B2
(en)
|
2018-09-18 |
2020-06-30 |
Crinetics Pharmaceuticals, Inc. |
Somatostatin modulators and uses thereof
|
|
US12617767B2
(en)
|
2019-07-17 |
2026-05-05 |
Crinetics Pharmaceuticals, Inc. |
Crystalline forms of somatostatin modulators
|
|
WO2022055880A1
(en)
|
2020-09-09 |
2022-03-17 |
Crinetics Pharmaceuticals, Inc. |
Formulations of a somatostatin modulator
|
|
JP2024520274A
(ja)
|
2021-05-25 |
2024-05-24 |
クリネティックス ファーマシューティカルズ，インク． |
疾患の治療のためのソマトスタチンモジュレータの使用
|